Fed Regist. 1999 Jul 2;64(127):35928-30.
This is a final rule of the Deputy Administrator of the Drug Enforcement Administration (DEA) transferring a drug between schedules of the Controlled Substances Act (CSA) pursuant to 21 U.S.C. 811. With the issuance of this final rule, the Deputy Administrator transfers from schedule II to schedule III of the CSA the drug containing synthetic dronabinol [(-) - [DELTA] less than 9 greater than - (trans)-tetrahydrocannabinol] in sesame oil and encapsulated in soft gelatin capsules in a product approved by the Food and Drug Administration (FDA). This rule also designates this drug as a schedule III non-narcotic substance requiring an import/export permit. As a result of this rule, the regulatory controls and criminal sanctions of schedule III will be applicable to the manufacture, distribution, importation and exportation of this drug.
这是美国缉毒局(DEA)副局长依据《美国法典》第21编第811条,在《管制物质法》(CSA)的不同附表之间转移一种药物的最终规则。随着本最终规则的发布,副局长将含有合成大麻二醇[(-)-[Δ9-(反式)-四氢大麻酚]、置于芝麻油中并封装在软胶囊内、经美国食品药品监督管理局(FDA)批准的一种产品中的药物,从CSA的附表II转移至附表III。本规则还将该药物指定为需要进出口许可证的附表III非麻醉物质。由于本规则,附表III的监管控制和刑事制裁将适用于该药物的生产、分销、进口和出口。